The study wasn't designed to assess the modified T-cells' ability to kill tumor cells, but the imaging results showed they did reach their targets.
The study was published Nov. 18 in the journal Nature Clinical Practice Oncology.
More information
The U.S. National Cancer Institute has more about biological therapies.
-- Robert Preidt
SOURCE: Stanford University, news release, Nov. 18, 2008
| Copyright©2008 ScoutNews,LLC. All rights reserved |